Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
1.
Epidemiol Prev ; 13(47): 55-8, 1991 Jun.
Article in Italian | MEDLINE | ID: mdl-1838507

ABSTRACT

We studied the prevalence of intestinal parasites in a random sample of immigrants and Italians employed in the food industry. Prevalence ranged from 20.8% among immigrants to 5.6% among Italians. Where helminths are widespread among Indochinese, protozoa are more common among africans. Three cases of Entamoeba histolytica in asymptomatic subjects were identified and successfully treated. We observed high levels of Giardia intestinalis both in Italians (2.2%) and immigrants (3.9%). Prevalence of intestinal protozoa was significantly associated with year of immigration, showing higher levels for new immigrants. The public health implications of parasite screening and treatment among recent immigrants were also discussed.


Subject(s)
Emigration and Immigration , Food Handling , Food-Processing Industry , Intestinal Diseases, Parasitic/epidemiology , Africa/ethnology , Asia/ethnology , Cross-Sectional Studies , Humans , Italy/epidemiology , Sampling Studies , South America/ethnology
2.
Digestion ; 39(4): 241-50, 1988.
Article in English | MEDLINE | ID: mdl-3220177

ABSTRACT

In a retrospective analysis of 78 well-defined patients, the procedure of the aminopyrine breath test was evaluated. After intravenous administration of 14C-aminopyrine (1.5 microCi, 1 mg) 14CO2 was sampled at 15-min intervals for 1 h. Samples taken at 15, 30, 45 and 60 min were similarly able to distinguish between patients with mild liver disease and patients with enzyme induction. The results of the aminopyrine breath test at each sampling time were highly correlated with the galactose elimination capacity and the fractional clearance of indocyanine green. It is concluded that sampling at 30 min represents a satisfactory compromise between practicality and accuracy of the test.


Subject(s)
Aminopyrine , Breath Tests , Liver Cirrhosis/diagnosis , Liver Function Tests , Adult , Aged , Fatty Liver/diagnosis , Fatty Liver, Alcoholic/diagnosis , Female , Hepatitis B/diagnosis , Humans , Infusions, Intravenous , Liver Cirrhosis, Alcoholic/diagnosis , Liver Cirrhosis, Biliary/diagnosis , Male , Middle Aged
3.
Schweiz Med Wochenschr ; 115(42): 1468-75, 1985 Oct 19.
Article in German | MEDLINE | ID: mdl-2866582

ABSTRACT

Bleeding from esophageal varices is a feared complication of liver cirrhosis with high mortality. Pharmacotherapy of the acute bleeding episode with vasopressin has been shown to be effective in controlled studies, but side effects of this therapy are high and therefore replacement of vasopressin with somatostatin is under investigation. Another potential lead is the combination of vasopressin with vasodilators such as nitroglycerin. While acute pharmacotherapy of the patient with esophageal varices is well accepted, chronic or prophylactic pharmacotherapy is still in the investigative stage. Prophylactic therapy with beta-blockers, e.g. propranolol, has been shown to be effective in compensated patients with alcoholic cirrhosis. In patients with more advanced stages of the disease, or with cirrhosis of other etiology, the effectiveness of propranolol has not been proven. The mechanism of propranolol is similar to that of vasopressin, i.e. it lowers portal pressure by reducing portal flow. To maintain function of the affected organ, an alternative approach--namely lowering of portal pressure through reduction of the pathologically elevated resistance--should be actively investigated.


Subject(s)
Adrenergic beta-Antagonists/therapeutic use , Hypertension, Portal/drug therapy , Vasopressins/therapeutic use , Acute Disease , Chronic Disease , Clinical Trials as Topic , Esophageal and Gastric Varices/complications , Esophageal and Gastric Varices/etiology , Gastrointestinal Hemorrhage/drug therapy , Gastrointestinal Hemorrhage/etiology , Humans , Hypertension, Portal/complications , Hypertension, Portal/physiopathology , Propranolol/therapeutic use , Random Allocation , Somatostatin/therapeutic use , Vasopressins/adverse effects
4.
Minerva Med ; 76(24): 1143-8, 1985 Jun 08.
Article in Italian | MEDLINE | ID: mdl-2409479

ABSTRACT

In order to estimate the validity of the discriminant function suggested by England e Fraser, we have determined the number of red cells (RBC) mean cell volume (MCV), hemoglobin mean concentration (MCV) and red cells distribution (RDW) in normal subjects, iron-deficient patients and uncomplicated thalassemia minor. The results obtained allow us to point out that RDW in the patients with thalassemia are higher than in normal subjects. In patients with iron-deficiency, instead, RDW medium is increased, but with a remarkable distribution of values. These results point out that anisocytosis is higher in iron-deficiency than in thalassemia.


Subject(s)
Anemia, Hypochromic/blood , Thalassemia/blood , Erythrocyte Count , Erythrocyte Indices , Fetal Hemoglobin , Hemoglobins , Humans , Iron/blood , Reticulocytes
SELECTION OF CITATIONS
SEARCH DETAIL
...